Browsing Category
Health
Sufferers on Eli Lilly drug regain weight after stopping it
Eli Lilly's drug tirzepatide was approved for weight loss by the FDA.Courtesy of Eli LillyPatients who took Eli Lilly's weight loss drug Zepbound regained…
New knowledge on Eli Lilly’s weight-loss drug reveals its outlook is shiny
The launch of Eli Lilly 's weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S.,…
How docs are utilizing Google’s new AI fashions for well being care
Sundar Pichai, CEO of Google and Alphabet, speaks on artificial intelligence during a Bruegel think tank conference in Brussels, Belgium, on Jan. 20,…
Vertex nonopioid painkiller posts constructive midstage trial outcomes
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019.Brian Snyder | ReutersShares of Vertex Pharmaceuticals…
Weight acquire after stopping Eli Lilly’s new weight problems remedy ought to assist, not harm…
Some Eli Lilly investors appear concerned about clinical trial data that showed patients regained weight after they stopped taking the company's obesity drug…
Cigna shares soar on deserted Humana buyout, buyback plans
Sopa Images | Lightrocket | Getty ImagesShares of Cigna jumped Monday following reports that the health-care giant has scrapped its plans to buy rival Humana…
Startup Orchid launches check to establish genetic defects in IVF embryos
Noor Siddiqui, founder and CEO of Orchid, during the web summit for careers during Day 2 of the 2014 Web Summit in Dublin, Ireland, Nov. 5, 2014.Stephen…
Eli Lilly weight reduction drug Zepbound accessible at U.S. pharmacies
The FDA approves Eli Lilly's Zepbound, a weight loss drug similar to Ozempic and Wegovy.Courtesy: Eli LillyEli Lilly on Tuesday said its recently approved…
U.S. poised to approve breakthrough therapy
At age 19, Joe Tsogbe underwent his first hip replacement. In his 20s, he averaged about nine hospitalizations a year. By his 30s, that rose to more than a…
First CRISPR gene-editing therapy authorised in U.S.
The U.S. Food and Drug Administration on Friday approved the country's first gene-editing treatment, Casgevy, for use in patients with sickle cell…